𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial

✍ Scribed by C Colombo; PM Battezzati; M Podda; N Bettinardi; A Giunta

Book ID
118686249
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
207 KB
Volume
23
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ursodeoxycholic acid for liver disease a
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-blind multicenter trial
✍ C Colombo; P M Battezzati; M Podda; N Bettinardi; A Giunta πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 204 KB πŸ‘ 1 views

AND THE ITALIAN GROUP FOR THE STUDY OF URSODEOXYCHOLIC ACID IN CYSTIC FIBROSIS\* ment. Thus, we concluded that UDCA administration im-Liver disease is increasingly recognized as a major proves clinical and biochemical parameters in CF pacause of morbidity in cystic fibrosis (CF). Preliminary tients

Ursodeoxycholic acid therapy in cystic f
Ursodeoxycholic acid therapy in cystic fibrosisβ€”associated liver disease: A dose-response study
✍ Carla Colombo; Andrea Crosignani; Marisa Assaisso; Pier Maria Battezzati; Mauro πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 668 KB

Previous studies from our groups have demonstrated improvements in biochemical markers of liver function when cystic fibrosis patients with associated liver disease were administered oral ursodeoxycholic acid. The magnitude of the response was somewhat less than that found when comparable doses (10